|
Age (years) (mean[± SD])
|
64.7 ± 15.8
|
67.5 ± 13
|
0.33
|
|
Male Sex (%)
|
64 (69.6)
|
46 (70.8)
|
0.87
|
|
BMI (kg/m2) (mean[± SD])
|
26.3 ± 4.1
|
31.5 ± 7.1
|
< 0.0001
|
|
CAD (%)
|
42 (45.7)
|
38 (58.5)
|
0.11
|
|
Angina (%)
|
8 (8.7)
|
5 (7.7)
|
0.83
|
|
Previous MI
|
35 (38)
|
31 (47.7)
|
0.23
|
|
Previous Revascularization (%)
|
9 (9.8)
|
4 (6.2)
|
0.42
|
|
Valve disease (%)
|
52 (56.5)
|
27 (41.5)
|
0.06
|
|
HTN (%)
|
51 (55.4)
|
44 (67.7)
|
0.12
|
|
DM - Insulin-Dependent (%)
|
8 (8.7)
|
14 (21.5)
|
0.02
|
|
DM - Non Insulin Dependent (%)
|
23 (25)
|
24 (36.9)
|
0.12
|
|
Dyslipidemia (%)
|
57 (62)
|
48 (73)
|
0.12
|
|
PVD (%)
|
9 (9.8)
|
11 (16.9)
|
0.19
|
|
CVD (%)
|
9 (9.8)
|
5 (7.7)
|
0.65
|
|
Creatinine (μmol/L) (mean[± SD])
|
102.1 ± 29.3
|
100.3 ± 24.1
|
0.98
|
|
Chronic Kidney Disease (%)
|
12 (13)
|
9 (13.8)
|
0.88
|
|
Pre-op SBP (mm Hg) (mean [± SD])
|
123.6 ± 21.1
|
129.5 ± 20.9
|
0.07
|
|
Pre-op DBP (mm Hg) (mean [± SD])
|
66.5 ± 13.3
|
67.4 ± 13.3
|
0.66
|
|
Pre-op MAP (mm Hg) (mean [± SD])
|
85.5 ± 13.2
|
88.1 ± 13.2
|
0.22
|
|
EF (%)(mean [± SD])
|
48.4 ± 13.2
|
47.5 ± 13.6
|
0.55
|
|
ASA (%)
|
76 (82.6)
|
54 (83.1)
|
0.90
|
|
Clopidogrel (%)
|
12 (13.0)
|
9 (13.8)
|
0.88
|
|
Beta-Blocker (%)
|
62 (67.5)
|
45 (69.2)
|
0.81
|
|
CCB (%)
|
17 (18.5)
|
11 (16.9)
|
0.08
|
|
ACE inhibitor (%)
|
56 (60.9)
|
31 (47.7)
|
0.10
|
|
ARB (%)
|
6 (6.5)
|
3 (4.6)
|
0.62
|
|
Statin (%)
|
60 (65.2)
|
46 (70.3)
|
0.46
|
|
Loop Diuretic (%)
|
34 (37)
|
28 (43.1)
|
0.44
|
|
Thiazide (%)
|
35 (38)
|
31 (47.7)
|
0.23
|
|
Spironolactone (%)
|
2 (2.2)
|
4 (6.2)
|
0.23
|
